{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "status": "retrieved", "company": "Swedish Orphan Biovitrum AB", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:40:35Z", "company": "Swedish Orphan Biovitrum AB", "title": "Delårsrapport för andra kvartalet 2026: Betydande tillväxt med viktiga framsteg i pipeline", "category": "Halvårsrapport", "date": "2026-07-16", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q2", "period": "2026-q2", "report_key": "2026:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b365e03256abb7257729b91f1fdb739b5&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\release.txt", "attachments": [ { "label": "07159325.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c", "final_url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c", "filename": "07159325.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\07159325.pdf", "content_type": "application/pdf", "size": 1175800, "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\07159325.pdf", "filename": "07159325.pdf", "extension": ".pdf", "size": 1175800, "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\07159325\\07159325.txt", "text_chars": 95367, "metadata": { "page_count": 35, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\07159325\\07159325.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1454349", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:40:39Z", "company": "Swedish Orphan Biovitrum AB", "title": "Delårsrapport för första kvartalet 2026: Stark leverans och viktiga framsteg i pipeline", "category": "Interimsrapport", "date": "2026-04-28", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bed68bf42c6b0537709ebdf78beb3fa2b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "04274767.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f", "final_url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f", "filename": "04274767.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\04274767.pdf", "content_type": "application/pdf", "size": 1145217, "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\04274767.pdf", "filename": "04274767.pdf", "extension": ".pdf", "size": 1145217, "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\04274767\\04274767.txt", "text_chars": 81834, "metadata": { "page_count": 33, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\04274767\\04274767.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1437561", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:41:12Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-31", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bbee04901d0f6d47c2d106193ba757199&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "03260875.pdf", "url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771", "final_url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771", "filename": "03260875.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\03260875.pdf", "content_type": "application/pdf", "size": 11113123, "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\03260875.pdf", "filename": "03260875.pdf", "extension": ".pdf", "size": 11113123, "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03260875\\03260875.txt", "text_chars": 803680, "metadata": { "page_count": 187, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03260875\\03260875.extraction.json" } } ], "announcement_id": "1430321", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:41:16Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2025: Året avslutas med betydande tillväxt och strategiska framsteg", "category": "Bokslutskommuniké", "date": "2026-02-05", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=be43ea8f84c7f543211d60ffb0ee38389&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "02046223.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2", "final_url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2", "filename": "02046223.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\02046223.pdf", "content_type": "application/pdf", "size": 4300090, "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\02046223.pdf", "filename": "02046223.pdf", "extension": ".pdf", "size": 4300090, "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02046223\\02046223.txt", "text_chars": 87369, "metadata": { "page_count": 34, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02046223\\02046223.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1418043", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:41:22Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för tredje kvartalet 2025: Accelererad tillväxt och momentum i portföljen", "category": "Interimsrapport", "date": "2025-10-20", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b71dc6f1b63155386dcbeaa46922c9138&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "10195737.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce", "final_url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce", "filename": "10195737.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\10195737.pdf", "content_type": "application/pdf", "size": 4029654, "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\10195737.pdf", "filename": "10195737.pdf", "extension": ".pdf", "size": 4029654, "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10195737\\10195737.txt", "text_chars": 95082, "metadata": { "page_count": 35, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10195737\\10195737.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1395126", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:41:26Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för andra kvartalet 2025: Fortsatt starkt momentum i portfölj och pipeline", "category": "Halvårsrapport", "date": "2025-07-16", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b0cf7fdf0365e2db9afdb4c2b3805d450&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "07159972.pdf", "url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186", "final_url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186", "filename": "07159972.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\07159972.pdf", "content_type": "application/pdf", "size": 4305181, "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\07159972.pdf", "filename": "07159972.pdf", "extension": ".pdf", "size": 4305181, "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07159972\\07159972.txt", "text_chars": 85283, "metadata": { "page_count": 34, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07159972\\07159972.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1379348", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:41:32Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för första kvartalet 2025: Portföljen fortsätter att leverera", "category": "Interimsrapport", "date": "2025-04-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2ced551b8b75d310c83a7ba33d19a3cc&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "04283614.pdf", "url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000", "final_url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000", "filename": "04283614.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\04283614.pdf", "content_type": "application/pdf", "size": 4255437, "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\04283614.pdf", "filename": "04283614.pdf", "extension": ".pdf", "size": 4255437, "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04283614\\04283614.txt", "text_chars": 71886, "metadata": { "page_count": 30, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04283614\\04283614.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1359030", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:02Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-03-31", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b6295957feca0dfeda661776c554f69ad&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "03277258.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8", "final_url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8", "filename": "03277258.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\03277258.pdf", "content_type": "application/pdf", "size": 15491514, "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\03277258.pdf", "filename": "03277258.pdf", "extension": ".pdf", "size": 15491514, "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03277258\\03277258.txt", "text_chars": 712072, "metadata": { "page_count": 168, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03277258\\03277258.extraction.json" } } ], "announcement_id": "1352386", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:05Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2024: Starkt avslut på ett framgångsrikt år", "category": "Bokslutskommuniké", "date": "2025-02-05", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b908a0f33e1d726c33c427edfe8364e84&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "02041851.pdf", "url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933", "final_url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933", "filename": "02041851.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\02041851.pdf", "content_type": "application/pdf", "size": 4250702, "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\02041851.pdf", "filename": "02041851.pdf", "extension": ".pdf", "size": 4250702, "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\02041851\\02041851.txt", "text_chars": 82419, "metadata": { "page_count": 32, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\02041851\\02041851.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1340849", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:11Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för tredje kvartalet 2024: Stark tillväxt och väsentliga framsteg i pipeline", "category": "Interimsrapport", "date": "2024-10-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b38af79e7e83c8ee2438b1d66ea802a36&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "10236498.pdf", "url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8", "final_url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8", "filename": "10236498.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\10236498.pdf", "content_type": "application/pdf", "size": 4251179, "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\10236498.pdf", "filename": "10236498.pdf", "extension": ".pdf", "size": 4251179, "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10236498\\10236498.txt", "text_chars": 83194, "metadata": { "page_count": 31, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10236498\\10236498.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1323230", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:16Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för andra kvartalet 2024: Stark leverans driven av robust utveckling i portföljen", "category": "Halvårsrapport", "date": "2024-07-16", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3ca6c22d01335bbc3ad7becda29f2f63&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "07155900.pdf", "url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8", "final_url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8", "filename": "07155900.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\07155900.pdf", "content_type": "application/pdf", "size": 4237718, "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\07155900.pdf", "filename": "07155900.pdf", "extension": ".pdf", "size": 4237718, "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07155900\\07155900.txt", "text_chars": 79272, "metadata": { "page_count": 32, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07155900\\07155900.extraction.json" } } ], "announcement_id": "1306629", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:22Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för första kvartalet 2024: Stark försäljning speglar styrkan i portföljen", "category": "Interimsrapport", "date": "2024-04-25", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf19a885a6ffb3ee929892e3dd31a5614&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "04247488.pdf", "url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f", "final_url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f", "filename": "04247488.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\04247488.pdf", "content_type": "application/pdf", "size": 4217948, "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\04247488.pdf", "filename": "04247488.pdf", "extension": ".pdf", "size": 4217948, "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04247488\\04247488.txt", "text_chars": 72854, "metadata": { "page_count": 31, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04247488\\04247488.extraction.json" } } ], "announcement_id": "1290546", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:44Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar sin års- och hållbarhetsredovisning för 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-02", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b674ba2f74fae1b353eb07c2629f99b0c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "03273911.pdf", "url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb", "final_url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb", "filename": "03273911.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\03273911.pdf", "content_type": "application/pdf", "size": 17247635, "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\03273911.pdf", "filename": "03273911.pdf", "extension": ".pdf", "size": 17247635, "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03273911\\03273911.txt", "text_chars": 610135, "metadata": { "page_count": 162, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03273911\\03273911.extraction.json" } } ], "announcement_id": "1285059", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:48Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2023: Stark intäktsutveckling och tillväxt in i 2024", "category": "Bokslutskommuniké", "date": "2024-02-08", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b82a48fcad5e4336da5c54b0ae1dd521d&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02073988.pdf", "url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c", "final_url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c", "filename": "02073988.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\02073988.pdf", "content_type": "application/pdf", "size": 4179875, "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\02073988.pdf", "filename": "02073988.pdf", "extension": ".pdf", "size": 4179875, "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02073988\\02073988.txt", "text_chars": 80677, "metadata": { "page_count": 30, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02073988\\02073988.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1273506", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:52Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för tredje kvartalet 2023: Stark försäljning och stabil leverans", "category": "Interimsrapport", "date": "2023-10-30", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b92ac36d21ba1be39d3c190e77f91cad2&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "10284167.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f", "final_url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f", "filename": "10284167.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\10284167.pdf", "content_type": "application/pdf", "size": 6041789, "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\10284167.pdf", "filename": "10284167.pdf", "extension": ".pdf", "size": 6041789, "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10284167\\10284167.txt", "text_chars": 81081, "metadata": { "page_count": 30, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10284167\\10284167.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1255803", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:42:57Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för andra kvartalet 2023: Tillväxt och utökad pipeline", "category": "Halvårsrapport", "date": "2023-07-18", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bcbbe240e554895c93760cb53d1624ffe&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "07174924.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b", "final_url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b", "filename": "07174924.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\07174924.pdf", "content_type": "application/pdf", "size": 6062432, "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\07174924.pdf", "filename": "07174924.pdf", "extension": ".pdf", "size": 6062432, "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07174924\\07174924.txt", "text_chars": 84136, "metadata": { "page_count": 33, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07174924\\07174924.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1238827", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T05:43:02Z", "company": "Swedish Orphan Biovitrum AB", "title": "Sobi publicerar delårsrapport för första kvartalet 2023: Fortsatt stabil utveckling", "category": "Interimsrapport", "date": "2023-04-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=baecfed01956ab788b0df2c9c5dd1fc8f&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "04267261.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606", "final_url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606", "filename": "04267261.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\04267261.pdf", "content_type": "application/pdf", "size": 5958918, "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\04267261.pdf", "filename": "04267261.pdf", "extension": ".pdf", "size": 5958918, "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04267261\\04267261.txt", "text_chars": 69614, "metadata": { "page_count": 29, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04267261\\04267261.extraction.json" } }, { "label": "här", "url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "final_url": "https://services3.choruscall.ch/NUMBERS/Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\Attended_Dial_In_Numbers.pdf", "content_type": "application/pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\Attended_Dial_In_Numbers.pdf", "filename": "Attended_Dial_In_Numbers.pdf", "extension": ".pdf", "size": 161243, "sha256": "7fe358b3d191e72f7fffd69345000061788c43a157d0043baf5343d6cffd255a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.txt", "text_chars": 1455, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\swedish-orphan-biovitrum-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\Attended_Dial_In_Numbers\\Attended_Dial_In_Numbers.extraction.json" } } ], "announcement_id": "1223094", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d40b1897676169c88d4b8854205f931aead11ee45999174736125d4e02effea6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "4b17cbe430821487ae50aa28bd75e0fe022d552a9ed62fdfeaea6a987222bdcc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "158e5d435dcbd585add2204b6441da6d57a727e2d92cd1950e8bd01135261398" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "4ad4d351ca680dfbf5e233f1072b4d5adea82e2fbf57271d985e94632806d094" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 20, "new_rows": 20, "total_count": null, "from_cache": false, "body_sha256": "cc79863b5914d8d737f7c2d3a36903a7e2bc3c976b58545d8f473d0623e2d373" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=420&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 420, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "efe89a1411715e378d0296250a2df2d35f1c2e3edc29d0b8c19679dbdfa5738b" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 7, "new_rows": 7, "total_count": null, "from_cache": false, "body_sha256": "0bc52752cd200029b92966ee73f97ff661292669835055754049e3d7e2f5e12e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=7&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 7, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "e47c2958927474c5024570b9522c21d79d7a42c4dafa8f9263473af76e0881fa" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "16ee9beb8db03a3d24d5a8f41e8d6a6bd5a7b9f9ee8cfad7fdacdb10b8a492c3" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2dcd5ad8fde7e4d7ea071af354e1ae2f297a9ace8d37a8ae2e1fc5e96f9c7c0f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "204d9255b0f8ac8c65238b9e2b37dfb8a86b4dedcfe8c77093d10cad7d92caf0" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "19948f9a305487a727489b897377edff5553f3795ee7c02fba7bb29add7b1e0a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 39, "new_rows": 39, "total_count": null, "from_cache": false, "body_sha256": "890978750e6b68a5271654fe5353a9dea9b726f9932cfaf1549df3fc50052c08" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=439&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 439, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "ceb34c0c72239c75d3d25f4d262d394169a3c8c45d95ec7b06af01d53f72948c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 8, "new_rows": 8, "total_count": null, "from_cache": false, "body_sha256": "5295af7f49458f5a4bbe8f4fdb35ac7f2805ffa23ab0d2df892108214a14d9c2" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Swedish+Orphan+Biovitrum&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=8&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 8, "pagination": "row-offset", "query_text": "Swedish Orphan Biovitrum", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "55f851bae00890b2e785c04c1fe6322bd70256e1e6d4d26272bd41a04cf045af" } ], "identity": { "slug": "sobi", "instrument_id": "TX211528", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/sobi?id=TX211528" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Swedish Orphan Biovitrum", "retrieved_at": "2026-08-04T05:43:02Z" }